Loading clinical trials...
Loading clinical trials...
Emergency Department Atrial Fibrillation Oral Diltiazem Observation Protocol
The primary objective of the study is to reduce hospital admission and decrease time to disposition through establishing an effective treatment protocol for AF and Atrial Flutter in the Emergency Department of Spectrum Health Lakeland. Secondary outcome is to measure if oral diltiazem is an effective HR controlling agent in AF RVR and Flutter.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Matthew Hysell
Saint Joseph, Michigan, United States
Start Date
June 19, 2020
Primary Completion Date
April 1, 2023
Completion Date
April 1, 2023
Last Updated
December 27, 2024
444
ACTUAL participants
Oral
DRUG
Intravenous drug
DRUG
Lead Sponsor
Corewell Health South
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05963698